Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

INSM

Insmed (INSM)

Insmed Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:INSM
DateHeureSourceTitreSymboleSociété
23/05/201912h04Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:INSMInsmed Inc
22/05/201912h03Edgar (US Regulatory)Free Writing Prospectus - Filing Under Securities Act Rules 163/433 (fwp)NASDAQ:INSMInsmed Inc
22/05/201902h56PR Newswire (US)Insmed Announces Pricing of Public Offering of Common StockNASDAQ:INSMInsmed Inc
20/05/201922h05PR Newswire (US)Insmed Announces Proposed Public Offering of Common StockNASDAQ:INSMInsmed Inc
20/05/201922h01PR Newswire (US)New Phase 3 Data Show Sustainability and Durability of Culture Conversion with ARIKAYCE® (amikacin liposome inhalation suspe...NASDAQ:INSMInsmed Inc
17/05/201922h07Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:INSMInsmed Inc
16/05/201923h19Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:INSMInsmed Inc
07/05/201913h31Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:INSMInsmed Inc
07/05/201913h30PR Newswire (US)Insmed Reports First Quarter 2019 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
30/04/201914h00PR Newswire (US)Insmed to Host First Quarter 2019 Financial Results Conference Call on Tuesday, May 7, 2019NASDAQ:INSMInsmed Inc
09/04/201922h36PR Newswire (US)Insmed Granted Additional U.S. Patent For ARIKAYCE® (amikacin liposome inhalation suspension), Strengthening Brand's Global ...NASDAQ:INSMInsmed Inc
08/04/201911h00PR Newswire (US)Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. LaunchNASDAQ:INSMInsmed Inc
04/04/201922h08Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:INSMInsmed Inc
04/04/201922h07Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:INSMInsmed Inc
02/04/201922h05PR Newswire (US)Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)NASDAQ:INSMInsmed Inc
01/04/201922h05PR Newswire (US)Insmed To Showcase New ARIKAYCE® (amikacin liposome inhalation suspension) And Pipeline Data At American Thoracic Society In...NASDAQ:INSMInsmed Inc
01/04/201914h00PR Newswire (US)Insmed to Present at the H.C. Wainwright Global Life Sciences ConferenceNASDAQ:INSMInsmed Inc
27/03/201921h15PR Newswire (US)Insmed Announces Management ChangesNASDAQ:INSMInsmed Inc
18/03/201916h32Edgar (US Regulatory)Confidential Treatment Order (ct Order)NASDAQ:INSMInsmed Inc
22/02/201913h33Edgar (US Regulatory)Annual Report (10-k)NASDAQ:INSMInsmed Inc
22/02/201913h30PR Newswire (US)Insmed Reports Fourth Quarter and Full Year 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
20/02/201914h00PR Newswire (US)Insmed to Present at the Leerink Partners 8th Annual Global Healthcare ConferenceNASDAQ:INSMInsmed Inc
15/02/201914h00PR Newswire (US)Insmed to Host Fourth Quarter and Full Year 2018 Financial Results Conference Call on Friday, February 22, 2019NASDAQ:INSMInsmed Inc
14/02/201923h55Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:INSMInsmed Inc
04/01/201922h05PR Newswire (US)Insmed Provides Update on ARIKAYCE® (amikacin liposome inhalation suspension) U.S. Launch and Outlines Strategic Priorities ...NASDAQ:INSMInsmed Inc
08/11/201822h09Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:INSMInsmed Inc
08/11/201814h30GlobeNewswire Inc.Insmed Announces Changes to its Board of DirectorsNASDAQ:INSMInsmed Inc
06/11/201814h30GlobeNewswire Inc.Insmed to Present at Three November ConferencesNASDAQ:INSMInsmed Inc
30/10/201812h30GlobeNewswire Inc.Insmed Reports Third Quarter 2018 Financial Results and Provides Business UpdateNASDAQ:INSMInsmed Inc
23/10/201814h30GlobeNewswire Inc.Insmed to Host Third Quarter 2018 Financial Results Conference Call on Tuesday, October 30, 2018NASDAQ:INSMInsmed Inc
 Showing the most relevant articles for your search:NASDAQ:INSM